Female Infertility

Female infertility

There are many biological causes (polycystic ovary//anovulatory//endometrial insufficiency) of infertility, including some that medical intervention can treat. Situations exist where multiple IVF have not worked, for reasons that cannot be elucidated by even the most sophisticated diagnostic methods and testing.

1. Anovulatory: lack of ova production can be primary or secondary to diseases like polycystic ovary etc

Ovarian rejuvenation & stimulation via transvaginal administration of stem cells makes the local microenvironment in ovaries favourable thus helps in production of healthy and functional ova.

2. Endometrial causes: leading to infertility are either nonspecific or secondary to diseases like Asherman syndrome, tuberculosis multiple abortions, D&C etc

MSCs tend to secrete antifibrotic, angiogenic, antiapoptotic, immune suppressive factors in a paracrine manner which promote the regeneration of the endometrial lining of the uterus

Stem cell application improves endometrial microenvironment (Endometrial rejuvenation) hence contributing towards promoting fertility and pregnancy in women esp. in Patients with poor endometrial growth despite hormonal treatment.

1. Anovulatory: lack of ova production can be primary or secondary to diseases like polycystic ovary etc

Ovarian rejuvenation & stimulation via transvaginal administration of stem cells makes the local microenvironment in ovaries favourable thus helps in production of healthy and functional ova.

2. Endometrial causes: leading to infertility are either nonspecific or secondary to diseases like Asherman syndrome, tuberculosis multiple abortions, D&C etc

MSCs tend to secrete antifibrotic, angiogenic, antiapoptotic, immune suppressive factors in a paracrine manner which promote the regeneration of the endometrial lining of the uterus

How it is done

Patients are evaluated for hormone levels, infectious genital disease, anatomical abnormalities of the genital tract as these issues if present need to be corrected first.
Patients advised to strictly avoid smoking, drug or alcohol consumption and have a positive life style

As a day care procedure 240 ml of Bone marrow and 100 ml of fat is aspirated and processed for stem cells isolation. 2 ml of stem cells processed is injected either

* Trans vaginal administration of cells in ovaries

* Into the feeding artery of ovaries and uterus

* in the Endometrium of uterus

*along with multiple flushing of platelet rich plasma in the uterine wall

What to expect

55 percent of women have shown evidence of live pregnancy within 6 to 9 months after undergoing the complete treatment protocol.

The endometrium grows up to 7 mm.

Pregnancy is achieved with embryo transfer in 50 % of cases .

90 % of patients experienced regular menstruation after the stem cell application

The website contains no medical advice. All statements and opinions provided by the website are for educational and informational purposes. ||The treatment centres associated with Revita lifesciences provide surgical procedure only and are not involved in use or manufacture of any investigational drug ||Revita does not claim that any application or potential application, using autologous stem cells are approved by the FDA. We do not claim that these procedures work for any listed nor unlisted condition, intended or implied.||It’s important for potential patients to do their own research based on the options we present so that one can make an informed decision. Any decision to participate in experimental protocol is completely voluntary ||

A to z of clinical and application based stem cell science under one roof